Shotaro Hirokawa

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Neoadjuvant Chemotherapy

Sentinel Lymph Node

Top Venues

Acta oto-laryngologica

This page only lists publications with an associated author ORCID identifier.

Publications

Shotaro Hirokawa, Koji Araki, Taku Yamashita, Kosuke Uno, Masayuki Tomifuji, Hideaki Shimada, Akihiro Shiotani
The value of serum p53 antibody as a biomarker in oral and pharyngeal squamous cell carcinoma. Acta oto-laryngologica (2023)
Shotaro Hirokawa, Koji Araki, Taku Yamashita, Kosuke Uno, Masayuki Tomifuji, Hideaki Shimada, Akihiro Shiotani
The value of serum p53 antibody as a biomarker in oral and pharyngeal squamous cell carcinoma. Acta oto-laryngologica 143 (1) (2023)
Shotaro Hirokawa, Koji Araki, Taku Yamashita, Kosuke Uno, Masayuki Tomifuji, Hideaki Shimada, Akihiro Shiotani
The value of serum p53 antibody as a biomarker in oral and pharyngeal squamous cell carcinoma. Acta oto-laryngologica 143 (1) (2023)
Shotaro Hirokawa, Koji Araki, Taku Yamashita, Kosuke Uno, Masayuki Tomifuji, Hideaki Shimada, Akihiro Shiotani
The value of serum p53 antibody as a biomarker in oral and pharyngeal squamous cell carcinoma. Acta oto-laryngologica 143 (1) (2023)
Shotaro Hirokawa, Koji Araki, Taku Yamashita, Kosuke Uno, Masayuki Tomifuji, Hideaki Shimada, Akihiro Shiotani
The value of serum p53 antibody as a biomarker in oral and pharyngeal squamous cell carcinoma. Acta oto-laryngologica 143 (1) (2023)